The severe asthma drugs industry is experiencing significant advancements, driven by innovations in therapeutic options and an increasing prevalence of severe asthma cases worldwide. As regulatory approvals and novel biologics gain momentum, this market is positioned for sustained growth with evolving market dynamics and rising patient awareness reflecting in the changing industry...